The University of Chicago Mesothelioma Research Program

The University of Chicago is consistently ranked among the top ten cancer programs in the country, and is led by a cadre of researchers who have made groundbreaking contributions to the study of the genetic and immunological processes that lead to cancer. The University of Chicago Cancer Research Center is designated a Clinical Cancer Center by the National Cancer Institute. As such, we conduct basic science research, research on populations of people at risk for cancer, and research with patients with cancer. Specifically, we conduct many clinical trials using novel agents to treat and prevent cancer.

Learn more about The University of Chicago Cancer Research Center

Each year over 100 new patients from across the nation and around the world seek the expertise of The University of Chicago Mesothelioma Program. Many enroll in promising clinical trials. As one of the largest mesothelioma treatment programs in the world, the University of Chicago has the excellence and expertise to provide state of the art care to our patients.

The University of Chicago Mesothelioma Program Research Team:

Director of the Thoracic Oncology Research Program

Ravi Salgia, MD, PD

Medical Oncology
Hedy Lee Kindler, MD

Surgical Oncology
Jai Raman, MD

Radiation Oncology
Philip Connell, MD

Imaging
Samuel G. Armato, PhD
Heber MacMahon, MD

Pathology
Aliya N. Husain, MD

Nursing

Tamara Guterz, RN

Data Management
Cynthia Bajda
Lisa Hanson